73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Research team reveals mechanisms at work in progression of pancreatic cysts to pancreatic cancer

Research team reveals mechanisms at work in progression of pancreatic cysts to pancreatic cancer

by University of California, San FranciscoPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic cysts have gained substantial

Research team reveals mechanisms at work in progression of pancreatic cysts to pancreatic cancer

by University of California, San FranciscoPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic cysts have gained substantial
Proximity to muscle cells may promote spread of prostate cancer cells, NIH study suggests

Proximity to muscle cells may promote spread of prostate cancer cells, NIH study suggests

by National Institutes of HealthFrom left to right: prostate cancer cells (square) near skeletal (oblong) and smooth (oval) muscle cells respond to Interleukins 4 and 13 (IL4/13) by producing ann

Proximity to muscle cells may promote spread of prostate cancer cells, NIH study suggests

by National Institutes of HealthFrom left to right: prostate cancer cells (square) near skeletal (oblong) and smooth (oval) muscle cells respond to Interleukins 4 and 13 (IL4/13) by producing ann
Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-
New drug, WNTinib, delays tumor growth and improves survival in mouse models of children's liver cancer

New drug, WNTinib, delays tumor growth and improves survival in mouse models of children's liver cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of

New drug, WNTinib, delays tumor growth and improves survival in mouse models of children's liver cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of
Researchers discover enzyme's role in 'natural killer T cell lymphoma'

Researchers discover enzyme's role in 'natural killer T cell lymphoma'

by National University of SingaporeThese findings potentiate an alternative treatment strategy for this aggressive disease. Credit: NUSNatural killer T cell lymphoma (NKTL) is an aggressive form

Researchers discover enzyme's role in 'natural killer T cell lymphoma'

by National University of SingaporeThese findings potentiate an alternative treatment strategy for this aggressive disease. Credit: NUSNatural killer T cell lymphoma (NKTL) is an aggressive form
30-minute exercise session found to increase proportion of tumor-killing white blood cells in the bloodstream

30-minute exercise session found to increase proportion of tumor-killing white blood cells in the bloodstream

byUniversity of TurkuExercise-induced changes in (A) total T cells, (B) CD4+helper T cells, (C) Th1 cells, (D) Th2 cells, (E) Th17 cells, (F) regulatory T cells, (G) CD8+cytotoxic T

30-minute exercise session found to increase proportion of tumor-killing white blood cells in the bloodstream

byUniversity of TurkuExercise-induced changes in (A) total T cells, (B) CD4+helper T cells, (C) Th1 cells, (D) Th2 cells, (E) Th17 cells, (F) regulatory T cells, (G) CD8+cytotoxic T
Cis-regulatory sequences indicative of nasopharyngeal carcinoma risk identified

Cis-regulatory sequences indicative of nasopharyngeal carcinoma risk identified

by Justin Jackson , Medical XpressCredit:The American Journal of Human Genetics(2023). DOI: 10.1016/j.ajhg.2023.06.003Research led by the Sun Yat-sen University Cancer Center in China has

Cis-regulatory sequences indicative of nasopharyngeal carcinoma risk identified

by Justin Jackson , Medical XpressCredit:The American Journal of Human Genetics(2023). DOI: 10.1016/j.ajhg.2023.06.003Research led by the Sun Yat-sen University Cancer Center in China has
Epigenetic age and lung cancer risk in a prospective cohort study

Epigenetic age and lung cancer risk in a prospective cohort study

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainEpigenetic age, a robust marker of biological aging, has been associated with obesity, low-grade inflammation and metabolic diseases. However, fe

Epigenetic age and lung cancer risk in a prospective cohort study

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainEpigenetic age, a robust marker of biological aging, has been associated with obesity, low-grade inflammation and metabolic diseases. However, fe
Fatty liver is increasingly the cause of liver cell cancer

Fatty liver is increasingly the cause of liver cell cancer

by Stefan Zorn, Medizinische Hochschule HannoverCredit: Pixabay/CC0 Public DomainHepatocellular carcinoma (HCC) is one of the most common cancers worldwide. In Germany, there are currently around 9,00

Fatty liver is increasingly the cause of liver cell cancer

by Stefan Zorn, Medizinische Hochschule HannoverCredit: Pixabay/CC0 Public DomainHepatocellular carcinoma (HCC) is one of the most common cancers worldwide. In Germany, there are currently around 9,00
Cancer drug data release set to power next wave of therapeutic discovery

Cancer drug data release set to power next wave of therapeutic discovery

by Wellcome Sanger InstituteCredit: CC0 Public DomainThis week (25 July) the Genomics of Drug Sensitivity in Cancer project has released the results of four years of intense data gathering and explora

Cancer drug data release set to power next wave of therapeutic discovery

by Wellcome Sanger InstituteCredit: CC0 Public DomainThis week (25 July) the Genomics of Drug Sensitivity in Cancer project has released the results of four years of intense data gathering and explora
Researchers to develop handheld device to diagnose skin cancer

Researchers to develop handheld device to diagnose skin cancer

by Stevens Institute of TechnologyStevens researchers develop a technique based on reflectivity patterns that can distinguish multiple forms of skin cancer, including basal cell carcinoma (left)

Researchers to develop handheld device to diagnose skin cancer

by Stevens Institute of TechnologyStevens researchers develop a technique based on reflectivity patterns that can distinguish multiple forms of skin cancer, including basal cell carcinoma (left)
Review covers progress in immunotherapy for esophageal cancer

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce